124 related articles for article (PubMed ID: 9795679)
1. Use of urokinase in pediatric hematology/oncology patients.
Kellerman S; Chan J; Jarvis W
Am J Infect Control; 1998 Oct; 26(5):502-6. PubMed ID: 9795679
[TBL] [Abstract][Full Text] [Related]
2. Urokinase for restoring patency of malfunctioning or blocked central venous catheters in children with hemato-oncological diseases.
Molinari AC; Haupt R; Saracco P; Di Marco M; Castagnola E; Fratino G
Support Care Cancer; 2004 Dec; 12(12):840-3. PubMed ID: 15365798
[TBL] [Abstract][Full Text] [Related]
3. Prophylaxis with urokinase in pediatric oncology patients with central venous catheters.
Kalmanti M; Germanakis J; Stiakaki E; Syfridaki C; Christidou A; Tsetis D; Vardas P; Charisis G
Pediatr Hematol Oncol; 2002; 19(3):173-9. PubMed ID: 11936730
[TBL] [Abstract][Full Text] [Related]
4. Continuous infusion of low-dose urokinase in the treatment of central venous catheter thrombosis in infants and children.
Bagnall HA; Gomperts E; Atkinson JB
Pediatrics; 1989 Jun; 83(6):963-6. PubMed ID: 2657625
[TBL] [Abstract][Full Text] [Related]
5. Clot lysis for thrombosed central venous catheters in pediatric patients.
Kellam B; Fraze D; Kanarek KS
J Perinatol; 1987; 7(3):242-4. PubMed ID: 3504465
[TBL] [Abstract][Full Text] [Related]
6. Alteplase versus urokinase for occluded hemodialysis catheters.
Zacharias JM; Weatherston CP; Spewak CR; Vercaigne LM
Ann Pharmacother; 2003 Jan; 37(1):27-33. PubMed ID: 12503929
[TBL] [Abstract][Full Text] [Related]
7. Investigational use of tissue plasminogen activator (t-PA) for occluded central venous catheters.
Atkinson JB; Bagnall HA; Gomperts E
JPEN J Parenter Enteral Nutr; 1990; 14(3):310-1. PubMed ID: 2112648
[TBL] [Abstract][Full Text] [Related]
8. Prospective Audit to Study urokinaSe use to restore Patency in Occluded centRal venous caTheters in haematology and oncology patients (PASSPORT 2).
Kumwenda MJ; Dougherty L; Jackson A; Hill S
J Vasc Access; 2021 Jul; 22(4):568-574. PubMed ID: 32867568
[TBL] [Abstract][Full Text] [Related]
9. Prospective analysis of urokinase in the treatment of catheter sepsis in pediatric hematology-oncology patients.
Jones GR; Konsler GK; Dunaway RP; Lacey SR; Azizkhan RG
J Pediatr Surg; 1993 Mar; 28(3):350-5; discussion 355-7. PubMed ID: 8468645
[TBL] [Abstract][Full Text] [Related]
10. Managing dysfunctional central venous access devices: a practical approach to urokinase thrombolysis.
Kumwenda M; Dougherty L; Spooner H; Jackson V; Mitra S; Inston N
Br J Nurs; 2018 Jan; 27(2):S4-S10. PubMed ID: 29368572
[TBL] [Abstract][Full Text] [Related]
11. Prophylactic urokinase in the management of long-term venous access devices in children: a Children's Oncology Group study.
Dillon PW; Jones GR; Bagnall-Reeb HA; Buckley JD; Wiener ES; Haase GM;
J Clin Oncol; 2004 Jul; 22(13):2718-23. PubMed ID: 15226339
[TBL] [Abstract][Full Text] [Related]
12. Recombinant urokinase is safe and effective in restoring patency to occluded central venous access devices: a multiple-center, international trial.
Svoboda P; Barton RP; Barbarash OL; Butylin AA; Jacobs BR; Lata J; Haire WD; Jaff MR; Firszt CM; Mouginis TL; Schuerr DM; Schulz GA; Schwartz LB; El-Shahawy MA
Crit Care Med; 2004 Oct; 32(10):1990-6. PubMed ID: 15483405
[TBL] [Abstract][Full Text] [Related]
13. The urokinase lock-therapy for hemodialysis occluded central venous catheters.
Li Cavoli G; Schillaci O; Zagarrigo C; Servillo F; Li Cavoli TV; Palmeri M; Rotolo U
Blood Purif; 2015; 39(1-3):238. PubMed ID: 25823425
[No Abstract] [Full Text] [Related]
14. Alteplase vs. urokinase for occluded hemodialysis catheter: A randomized trial.
Pollo V; DionÃzio D; Bucuvic EM; Castro JH; Ponce D
Hemodial Int; 2016 Jul; 20(3):378-84. PubMed ID: 26851872
[TBL] [Abstract][Full Text] [Related]
15. Urokinase administration in pediatric patients with occluded central venous catheters.
Wachs T
J Intraven Nurs; 1990; 13(2):100-2. PubMed ID: 2313458
[TBL] [Abstract][Full Text] [Related]
16. Thrombosed central venous catheters: restoring function with 6-hour urokinase infusion after failure of bolus urokinase.
Haire WD; Lieberman RP
JPEN J Parenter Enteral Nutr; 1992; 16(2):129-32. PubMed ID: 1556806
[TBL] [Abstract][Full Text] [Related]
17. [Treatment of obstruction and thrombosis due to central venous catheterization].
Leititis JU
Klin Padiatr; 1991; 203(6):420-3. PubMed ID: 1758144
[TBL] [Abstract][Full Text] [Related]
18. Thrombolytic Therapy Using Urokinase for Management of Central Venous Catheter Thrombosis.
Son JT; Min SY; Kim JI; Choi PW; Heo TG; Lee MS; Kim CN; Kim HY; Yi SY; Lee HR; Roh YN
Vasc Specialist Int; 2014 Dec; 30(4):144-50. PubMed ID: 26217634
[TBL] [Abstract][Full Text] [Related]
19. Developing a protocol to prevent and treat pediatric central venous catheter occlusions.
Harris JL; Maguire D
J Intraven Nurs; 1999; 22(4):194-8. PubMed ID: 10476135
[TBL] [Abstract][Full Text] [Related]
20. A prospective double-blind randomized trial of urokinase flushes to prevent bacteremia resulting from luminal colonization of subcutaneous central venous catheters.
Aquino VM; Sandler ES; Mustafa MM; Steele JW; Buchanan GR
J Pediatr Hematol Oncol; 2002 Dec; 24(9):710-3. PubMed ID: 12468909
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
